Rxcurve
HCPCS J2430 · per 30 MG

Pamidronate disodium /30 mg

Products billed under this code include Pamidronate Disodium.

Payment limit per 30 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J2430

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Pamidronate Disodium Pfizer Inc 61703-0324-18 1 $11.306
Pamidronate Disodium Pfizer Inc 61703-0325-18 2 $22.612
Pamidronate Disodium Pfizer Inc 61703-0326-18 3 $33.918
Pamidronate Disodium Mylan Institutional LLC 67457-0430-10 1 $11.306
Pamidronate Disodium Mylan Institutional LLC 67457-0446-10 3 $33.918

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $11.306 −$0.719 30 MG Pamidronate disodium /30 mg v1, posted September 17, 2026
3Q26 $12.025 −$0.399 30 MG Pamidronate disodium /30 mg v1, posted September 15, 2026
2Q26 $12.424 +$1.134 30 MG Pamidronate disodium /30 mg v1, posted September 15, 2026
1Q26 $11.29 +$1.647 30 MG Pamidronate disodium /30 mg v1, posted September 15, 2026
4Q25 $9.643 −$1.517 30 MG Pamidronate disodium /30 mg v1, posted September 8, 2026
3Q25 $11.16 −$2.716 30 MG Pamidronate disodium /30 mg v1, posted March 10, 2026
2Q25 $13.876 +$1.293 30 MG Pamidronate disodium /30 mg v1, posted March 10, 2026
1Q25 $12.583 −$0.031 30 MG Pamidronate disodium /30 mg v1, posted December 19, 2025
4Q24 $12.614 +$0.947 30 MG Pamidronate disodium /30 mg v1, posted June 11, 2025
3Q24 $11.667 −$2.43 30 MG Pamidronate disodium /30 mg v1, posted June 11, 2025
2Q24 $14.097 +$5.223 30 MG Pamidronate disodium /30 mg v1, posted March 11, 2025
1Q24 $8.874 −$1.458 30 MG Pamidronate disodium /30 mg v1, posted December 19, 2024
4Q23 $10.332 +$0.016 30 MG Pamidronate disodium /30 mg v1, posted October 10, 2024
3Q23 $10.316 −$0.254 30 MG Pamidronate disodium /30 mg v1, posted June 5, 2024
2Q23 $10.57 +$0.19 30 MG Pamidronate disodium /30 mg v1, posted February 23, 2024
1Q23 $10.38 −$0.601 30 MG Pamidronate disodium /30 mg v1, posted December 6, 2023
4Q22 $10.981 +$0.405 30 MG Pamidronate disodium /30 mg v1, posted June 22, 2023
3Q22 $10.576 +$0.425 30 MG Pamidronate disodium /30 mg v1, posted June 9, 2023
2Q22 $10.151 −$0.403 30 MG Pamidronate disodium /30 mg v1, posted December 14, 2022
1Q22 $10.554 +$1.396 30 MG Pamidronate disodium /30 mg v1, posted June 8, 2022
4Q21 $9.158 +$0.846 30 MG Pamidronate disodium /30 mg v1, posted June 2, 2022
3Q21 $8.312 −$1.834 30 MG Pamidronate disodium /30 mg v1, posted June 2, 2022
2Q21 $10.146 −$0.558 30 MG Pamidronate disodium /30 mg v1, posted March 1, 2022
1Q21 $10.704 – 30 MG Pamidronate disodium /30 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files